| Business Summary | | Positron
Corporation
designs,
manufactures,
markets
and
services
advanced
medical
imaging
devices
utilizing
positron
emission
tomography
(PET)
technology,
under
the
name
Posicam
systems.
PET
technology
permits
the
measurement
of
the
biological
processes
of
organs
and
tissues
as
well
as
producing
anatomical
and
structural
images.
Posicam
systems,
which
incorporate
patented
and
proprietary
technology,
enable
physicians
to
diagnose
and
treat
patients
in
the
areas
of
cardiology,
neurology
and
oncology.
The
Food
and
Drug
Administration
(FDA)
approved
the
initial
Posicam
system
for
marketing
in
1985,
and
as
of
December
31,
2000,
the
Company
had
sold
21
Posicam
systems,
of
which
13
are
in
medical
facilities
in
the
United
States
and
five
are
installed
in
international
medical
institutions. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Positron
designs,
manufactures,
markets
and
services
advanced
medical
imaging
devices,
which
utilize
positron
emission
tomography
(``PET'')
technology
under
the
tradename
POSICAM
systems.
PET
measures
the
biological
processes
of
organs
and
tissues.
For
the
six
months
ended
6/30/01,
total
revenue
fell
65%
to
$942
thousand.
Net
loss
rose
from
$469
thousand
to
$1.3
million.
Revenues
reflect
the
absence
of
any
system
sales.
Higher
loss
reflects
an
increase
in
operating
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| S. Lewis Meyer, Ph.D., 56 Chairman | -- | Gary Brooks, 52 Pres,
Acting CFO, Sec. | $202K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|